journal article·2020-04

Electrostatic self-assembled Iridium(III) nano-photosensitizer for selectively disintegrated and mitochondria targeted photodynamic therapy

Yong Deng, Shunjie Pan, Jiajun Zheng, Yale Hong, Jie Liu, Haizhou Chang, Yuqing Miao, Yun Sun, Yuhao Li

Dyes and Pigments· Volume 175
Publisher page

Abstract

Abstract Photodynamic therapy (PDT) is one of effective cancer therapy methods. It is important to develop a PDT reagent with tumor-targeted ability, high phototoxicity and low dark toxicity. In this study, an iridium(III) complex (Irpy) can electrostatically self-assemble with hyaluronic acid (HA) to form nanostructured Irpy-HA, which exhibited stable spheroid structure and outstanding ability of singlet oxygen (1O2) generation. The photophysical property of Irpy has been well studied, which qualified green light absorption ability and could emit red phosphorescence. The nanostructure and stability of self-assembled Irpy-HA have been well investigated, which can keep its nanostructure at least 30 days. More importantly, Irpy-HA can target to a CD44 receptor in cancer cell membrane for enhancing internalization and selective disintegration. Then, Irpy can accumulate in mitochondria and generate 1O2 to realize PDT-induced cell apoptosis by green light irradiation. The Irpy-HA could be used as a nanophotosensitizer for effective photodynamic therapy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (31)

Show source-provided references
1. Nanoparticles in photodynamic therapy10.1021/cr5004198 ↗
2. Molecular interactions in organic nanoparticles for phototheranostic applications10.1021/acs.chemrev.5b00140 ↗
3. The problem with dyes in infection control10.1016/j.dyepig.2017.07.042 ↗
4. Inactivation kinetics and lethal dose analysis of antimicrobial blue light and photodynamic therapy10.1016/j.pdpdt.2019.08.022 ↗
5. Photodynamic therapy for cancer10.1038/nrc1071 ↗
6. Photodynamic therapy of cancer: an update
7. AIE multinuclear Ir(III) complexes for biocompatible organic nanoparticles with highly enhanced photodynamic performance10.1002/advs.201802050 ↗
8. Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy10.1016/j.ccr.2018.03.020 ↗
9. Enhancing singlet oxygen generation in semiconducting polymer nanoparticles through fluorescence resonance energy transfer for tumor treatment10.1039/C8SC05501G ↗
10. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
11. Cell permeable NBD peptide-modified liposomes by hyaluronic acid coating for the synergistic targeted therapy of metastatic inflammatory breast cancer10.1021/acs.molpharmaceut.8b01123 ↗
12. Nanoplatform assembled from a CD44-targeted prodrug and smart liposomes for dual targeting of tumor microenvironment and cancer cells10.1021/acsnano.7b08051 ↗
13. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44 overexpressing tumor cells
14. Cancer-mitochondria-targeted photodynamic therapy with supramolecular assembly of HA and a water soluble NIR cyanine dye10.1039/C7SC03169F ↗
15. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo10.1016/j.biomaterials.2010.11.010 ↗
16. Self-assembled hyaluronic acid nanoparticles for active tumor targeting10.1016/j.biomaterials.2009.09.030 ↗
17. Mitochondria-targeted colorimetric and fluorescent probes for hypochlorite and their applications for in vivo imaging10.1039/C4CC02673J ↗
18. A mitochondria-targeted photosensitizer showing improved photodynamic therapy effects under hypoxia10.1002/anie.201604130 ↗
19. Photofunctional triplet excited states of cyclometalated Ir(III) complexes: beyond electroluminescence10.1039/c2cs35171d ↗
20. Nonlinear absorbing cationic iridium(III) complexes bearing benzothiazolylfluorene motif on the bipyridine (N^N) ligand: synthesis, photophysics and reverse saturable absorption10.1021/am401133p ↗
21. Effects of extended π-conjugation in phenanthroline (N^N) and phenylpyridine (C^N) ligands on the photophysics and reverse saturable absorption of cationic heteroleptic iridium(III) complexes10.1021/jp411259f ↗
22. Increasing the triplet lifetime and extending the ground-state absorption of biscyclometalated Ir(III) complexes for reverse saturable absorption and photodynamic therapy applications10.1039/C6DT02416E ↗
23. Temperature dependence of the photophysical and photochemical properties of the tris(2,2'-bipyridyl)ruthenium(II) ion in aqueous solution10.1021/ja00432a028 ↗
24. Photosensitized singlet oxygen and its applications10.1016/S0010-8545(02)00034-6 ↗
25. Photophysical and photobiological properties of dinuclear iridium(III) bis-tridentate complexes10.1021/acs.inorgchem.8b00789 ↗
26. Real-time monitoring of the mitophagy process by a photostable fluorescent mitochondrion-specific bioprobe with AIE characteristics10.1039/C5CC02486B ↗
27. Mitochondrion-specific live-cell bioprobe operated in a fluorescence turn-on manner and a well-designed photoactivatable mechanism10.1002/adma.201503751 ↗
28. Room-temperature NIR phosphorescence of new iridium (III) complexes with ligands derived from benzoquinoxaline10.1139/v05-253 ↗
29. Phosphorescent heavy-metal complexes for bioimaging10.1039/c0cs00114g ↗
30. Using substituted cyclometalated quinoxaline ligands to finely tune the luminescence properties of iridium(III) complexes10.1021/ic301853t ↗
31. Bifunctional platinated nanoparticles for photoinduced tumor ablation10.1002/adma.201602738 ↗